SB 161
10 links on this map: who funds them, what they touched, and who lobbied on it. Select anyone to move the map to them.
Start with
and connect to
Browse all held record sources
Zoom to read. Drag to explore. Select a connection.
Every link on this map
The same connections as a table, with the reason each one is here.
| Roderick Wright | Sponsors | Roderick Wright sponsored SB 161. | None |
| Blue Shield of California | Lobbied on it | Blue Shield of California named SB 161 in 3 lobbying reports. | 3 reports |
| Genentech, Inc., A Member of the Roche Group | Lobbied on it | Genentech, Inc., A Member of the Roche Group named SB 161 in 3 lobbying reports. | 3 reports |
| GSK | Lobbied on it | GSK named SB 161 in 3 lobbying reports. | 3 reports |
| Astrazeneca Pharmaceuticals, LP | Lobbied on it | Astrazeneca Pharmaceuticals, LP named SB 161 in 2 lobbying reports. | 2 reports |
| Millennium Pharmaceuticals Inc. | Lobbied on it | Millennium Pharmaceuticals Inc. named SB 161 in 2 lobbying reports. | 2 reports |
| Susan G. Komen for the Cure Advocacy Alliance | Lobbied on it | Susan G. Komen for the Cure Advocacy Alliance named SB 161 in 2 lobbying reports. | 2 reports |
| Sanofi US | Lobbied on it | Sanofi US named SB 161 in 2 lobbying reports. | 2 reports |
| Association of Northern California Oncologists | Lobbied on it | Association of Northern California Oncologists named SB 161 in 1 lobbying report. | 1 report |
| Health care coverage: cancer treatment. | Source records | SB 161 has an explicit source reference to Health care coverage: cancer treatment.. | None |
In the news
Reporting about the selected subject. Articles are context and do not establish a connection on this map.
Loading coverage…